Should Palatine Tonsils be Included in the Oropharyngeal Swab for SARS-CoV-2 Molecular Testing?
NCT05611203 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2023-01-11
Summary
Citizens who undergo testing for COVID-19 at one of two Testcenters in Copenhagen Captial Region will be invited to participate in the study. The participants will be randomized to either an oropharyngeal swap including the palatine tonsils OR an oropharyngeal swap without the palatine tonsils for SARS-CoV-2 testing. The swabs will be sent to the clinical microbiology laboratory for SARS-CoV-2 detection using RT-PCR. The diagnostic accuracy and SARS-CoV-2 viral load will be compared. The participants will be asked to complete a questionnaire regarding their symptoms.
Conditions
- SARS-CoV Infection
- Coronavirus
- Corona Virus Infection
Interventions
- PROCEDURE
-
An Oropharyngeal swab
An Oropharyngeal swab performed for diagnostic purposes
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-11-10
- Primary Completion
- 2023-01-30
- Completion
- 2023-03-02
Countries
- Denmark
Study Locations
More Related Trials
-
Telemedically Assisted Sampling of COVID-19 Patients - Is the Sampling Quality Sufficient
NCT05386407 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of the Efficacy and Safety of Zinc in Viral Infections
NCT05212480 ·Status: COMPLETED ·Phase: NA
-
A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza
NCT03336619 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Zinc Acetate Lozenges on the Rate of Recovery From the Common Cold
NCT03309995 ·Status: COMPLETED ·Phase: NA
-
Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
NCT02612922 ·Status: COMPLETED ·Phase: PHASE3
-
Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients
NCT04621123 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19: Salvage TOcilizumab as a Rescue Measure
NCT04577534 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Obeldesivir in Nonhospitalized Participants With COVID-19
NCT05715528 ·Status: COMPLETED ·Phase: PHASE3
-
Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.
NCT03212716 ·Status: TERMINATED ·Phase: PHASE2
-
Collection of RNA Extracted From Nasopharyngeal and Saliva Samples From Same Patients With Suspicion of Covid-19
NCT04949074 ·Status: COMPLETED
-
An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients
NCT04471051 ·Status: COMPLETED
-
Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized Patients
NCT04354831 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir
NCT05567952 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness
NCT05603143 ·Status: TERMINATED ·Phase: PHASE3
-
COVID-19 Molecular OTC At Home Test
NCT05704803 ·Status: COMPLETED ·Phase: NA
-
Quantification of Viral Load in the Upper Respiratory Tract in Patients Treated With Olsetamivir for Influenza
NCT04515446 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19
NCT05689203 ·Status: UNKNOWN ·Phase: PHASE2
-
A Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza
NCT02561169 ·Status: TERMINATED ·Phase: PHASE4
-
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
NCT01992276 ·Status: WITHDRAWN ·Phase: PHASE2
-
Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19
NCT04467151 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)
NCT04547127 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19
NCT04522830 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients
NCT04475120 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and the Antiviral Activity of Multiple Doses in an Influenza Challenge Study
NCT02588521 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19
NCT05506176 ·Status: COMPLETED ·Phase: PHASE2/PHASE3